OnePage Money - Your news on time is priceless

US markets are under pressure as U.S. strikes on Iran and rising oil prices push Brent above $90, stoke inflation fears, and weigh on stock index futures.

Analysts highlight stocks and sectors to avoid or watch closely around upcoming earnings, rate moves, and September seasonality, warning of potential “blow‑ups” and market overhangs.
Investors are pointed to some of the highest-yielding CDs and attractive bond opportunities as rising yields and Fed uncertainty keep fixed income in focus.
AI-driven demand for data center cooling is boosting interest in HVAC and related industrial stocks, with several analysts and investors targeting names positioned to benefit.
Specific companies such as Snowflake, Micron, Howmet, and an aluminum producer are under the spotlight for earnings, valuation, and competitive threats, with mixed views from different firms.
Broader market commentary suggests Wall Street is finishing a strong month, but experts warn September could be more volatile due to higher rates, oil prices, and geopolitical risks.
GLP-1 obesity drugs, AI healthcare applications, and other growth niches are drawing attention as their markets become larger and more competitive.
Major corporate moves include Aon’s $17 billion deal for USI Insurance Services, public offerings, tech/media expansions, and new campaigns targeting Gen Z consumers.
Legal and regulatory battles intensify, with lawsuits over AI’s use of copyrighted content, scrutiny of private equity’s role in law firms, and potential FTC action against Amazon’s ad pricing.
Geopolitical tensions—particularly involving Trump’s Iran and Venezuela policies, U.S. strikes to protect Hormuz, and Middle East flare‑ups—are pushing Brent crude above $90 and stirring inflation worries.
Commodities, travel “shoulder season” changes, and lifestyle trends (like shifts in fall coffee favorites) round out the picture of evolving consumer behavior and global economic conditions.

Hong Kong stocks slipped slightly with the Hang Seng down 17 points as new property market policies pressured mainland developers, while Shein’s pre-listing dark pool trading saw shares plunge up to 28%, highlighting heightened volatility around major Hong Kong IPOs.

The Observatory will keep the No.1 Standby Signal in force at least until tomorrow noon and will then assess whether it needs to be upgraded to the No.3 Strong Wind Signal, with issuance of Signal No.1 scheduled at 6:10 pm.
Hong Kong southbound Stock Connect saw a net outflow of HK$949 million, while the Hang Seng Index fell 17 points; AI firm Zhizhu (智譜) rose nearly 10%, and mainland property stocks came under pressure from new housing policies.
Several major earnings reports show mixed performance: Horizon turned profitable in the interim period with RMB 3.784 billion net profit but its adjusted loss widened to RMB 1.671 billion; MOMENTA’s interim loss expanded to RMB 16.537 billion though its adjusted loss narrowed sharply to RMB 14.1 million; Evergrande Property’s interim net profit grew 9.5% to RMB 517 million; CITIC Financial Asset’s interim net profit rose 11.3% to RMB 6.862 billion.
Brokerages and financial stocks were strong: CITIC Ltd’s share price rose 2% after Citi raised its target price to HK$15.85 and highlighted enhanced shareholder-return commitment; CICC’s interim results showed revenue up 50.5% and net profit up 89.3% to RMB 8.199 billion, with ROE improving to 7.6%; overall, 43 listed A-share brokers’ first-half revenue and net profit both surged by around 45–49%.
Major broker research calls reshuffled valuations: JPMorgan and CMB International both upgraded Hansoh Pharma’s target prices (to HK$50 and HK$49.12) on better-than-expected interim results; Deutsche Bank cut Akeso Bio’s target to HK$127 on weaker-than-expected earnings; Goldman Sachs lowered WH Group’s target to HK$10.9 after slightly disappointing Q2; BofA downgraded Yuexiu Property to “underperform” and slashed its target by 28% to HK$3.6; Citi raised Fosun International’s target to HK$6.3 citing reduced NAV discount from potential listings and placed C&D International under 30‑day downside watch after a 16% plunge.
Shein’s new listing faced volatility, with grey-market trading at one point dropping nearly 28% and each board lot posting a paper loss of over HK$1,300, highlighting investor caution around new-economy IPOs despite heavyweight cornerstone investors such as Boyu Capital, Tencent, Jinglin, and Taikang Life.
A-share interim reporting paints AI as the core growth engine: out of 5,550 listed companies already reporting, AI demand—from chips to computing power services—has driven explosive earnings growth for leaders like Cambricon and Jiangbolong; AI is now moving from R&D and infrastructure into broad, industry-wide applications, becoming a key driver of “new-quality” productivity.
China’s computing-power infrastructure is being elevated to national “basic resource” status: the country is building a unified “computing power network” based on 8 national hubs, 10 clusters, and 3 compute‑electricity coordination zones, shifting from isolated data centers to a nationwide, cross‑region coordinated grid to make using compute as convenient as using electricity, with smart compute expected to be 500 times 2020 levels by 2030.
Policy support and capital flows are reshaping markets: new, comprehensive real-estate policies aim to reform presale systems, strengthen closed management of development and mortgage funds, and accelerate a shift toward completed‑home sales; multiple financing rules seek to foster a virtuous cycle between finance and property; the State Administration of Foreign Exchange expanded QDII quotas beyond US$100 billion, giving public funds more “ammo” for cross-border investment while raising the bar for risk control and asset allocation.
Medical and AI‑pharma sectors are entering a new high‑prosperity phase: among 508 A-share pharma firms reporting, 191 saw year‑on‑year profit growth and 40 exceeded 100%; policy support plus talent and R&D advantages are boosting domestic innovative drugs and global competitiveness; AI‑driven pharma in Hong Kong (the “three small dragons”) showed clear improvement, and over half of 73 A-share AI‑pharma concept stocks reported profit growth, indicating a shift from pure tech exploration toward tangible commercial value.

Japan’s long-term interest rates climbed to 2.95%, the highest level in nearly 30 years and nearing the key 3% threshold, triggering a sharp sell-off on the Tokyo Stock Exchange amid heightened concern over U.S. rate hikes and domestic policy shifts.

Major banks Mitsubishi UFJ and Sumitomo Mitsui will raise variable-rate housing loan interest from September, reflecting the Bank of Japan’s policy rate hike.
The government will request a budget 3.6 times larger to eliminate “transportation gaps,” aiming to cut annual economic losses of 10 trillion yen and promote ride-sharing and autonomous driving.
The Takaichi administration plans budget reform to strengthen market confidence, expanding expenditures with new government bond issuance targeted at around 40 trillion yen.
Draft budget requests will total around 143 trillion yen for the fourth straight record high, driven by a new growth investment framework integrated with supplementary budgets.
About 1.5472 trillion yen will be requested for economic security to establish autonomy in strategic resources and critical materials such as rare earths.
China’s business sentiment weakened in August, falling below a key threshold for the second consecutive month.
Japan’s long-term interest rate climbed to 2.950%, the highest level in about 29 years and 10 months, putting the symbolic 3% level within sight.
The Tokyo stock market temporarily fell by more than 1,500 yen amid selling pressure due to concerns over further U.S. interest rate hikes.
The U.S. Treasury Secretary expressed hope for “appropriate action” by the Bank of Japan on yen depreciation and plans to discuss the issue at the G20 meeting.
The Ministry of Agriculture will buy back 210,000 tons of reserve rice via a negotiated contract around September 18, anticipating a bumper new rice crop.

Bitcoin faces a critical three-way macro test near $78,000, potentially setting the tone for the broader crypto market despite bullish signals in XRP and strengthening support for Ethereum.

Ripple announced a four-stage plan to strengthen its systems against future quantum computing threats, raising speculation that XRP could gain from improved security and investor confidence.
Cardano’s blockchain is now used to anchor 500,000 supply-chain records, providing public, verifiable proof of data and showcasing ADA’s utility in real-world tracking and transparency.
Polygon has secured its Bor and Heimdall clients prior to publicly disclosing vulnerabilities, indicating proactive risk management and a focus on network resilience.
Arthur Hayes has expressed support for Ethereum, arguing that ETH is gaining strength versus Bitcoin and may outperform as its ecosystem and use cases expand.
Bitcoin is approaching a key zone near $78,000, where it faces a convergence of macroeconomic pressures, technical levels, and market sentiment that could shape its next major move.
A key on-chain or technical metric for XRP has turned bullish, leading some analysts to project a possible price move toward the $2 level if momentum continues.
Progress on the CLARITY Act, meant to provide clearer crypto regulation in the U.S., has stalled, coinciding with recent weakness and outflows in spot Bitcoin ETFs.
XRP’s price is testing an important support area after its strong August rally faded, making this level critical for determining whether the uptrend can resume.
Across these stories, large-cap altcoins like XRP, ADA, and ETH are emphasizing security, regulatory clarity, and real-world use cases to attract institutional and retail interest.
Market participants are closely watching both macro conditions and protocol-level developments, as they increasingly drive divergent performance among Bitcoin, Ethereum, XRP, Cardano, and Polygon.

Disclaimer:
The information provided on this website is for informational and educational purposes only and should not be construed as financial, investment, trading, or other professional advice. All opinions, analyses, and commentary reflect the personal views of the respective authors and do not constitute recommendations to buy, sell, or hold any assets, securities, or cryptocurrencies. While every effort is made to ensure the accuracy and timeliness of the information presented, no warranty, express or implied, is given regarding its completeness, reliability, or suitability. Financial markets, particularly cryptocurrencies and digital assets, involve significant risk and volatility. You should conduct your own research, seek independent advice from licensed financial advisors, and assess your risk tolerance before making any investment decisions. The website, its contributors, and affiliates assume no liability for losses or damages arising from the use of or reliance on any information contained herein. External links are provided for convenience and informational purposes only; the site has no control over and assumes no responsibility for their content or policies. By using this website, you acknowledge and agree to these terms.